These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 12384258)

  • 21. Activation of D1, but not D2 receptors potentiates dizocilpine-mediated disruption of prepulse inhibition of the startle.
    Bortolato M; Aru GN; Fà M; Frau R; Orrù M; Salis P; Casti A; Luckey GC; Mereu G; Gessa GL
    Neuropsychopharmacology; 2005 Mar; 30(3):561-74. PubMed ID: 15328529
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Toward understanding the biology of a complex phenotype: rat strain and substrain differences in the sensorimotor gating-disruptive effects of dopamine agonists.
    Swerdlow NR; Martinez ZA; Hanlon FM; Platten A; Farid M; Auerbach P; Braff DL; Geyer MA
    J Neurosci; 2000 Jun; 20(11):4325-36. PubMed ID: 10818168
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Seroquel, clozapine and chlorpromazine restore sensorimotor gating in ketamine-treated rats.
    Swerdlow NR; Bakshi V; Waikar M; Taaid N; Geyer MA
    Psychopharmacology (Berl); 1998 Nov; 140(1):75-80. PubMed ID: 9862405
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparing the effects of 17β-oestradiol and the selective oestrogen receptor modulators, raloxifene and tamoxifen, on prepulse inhibition in female rats.
    Gogos A; van den Buuse M
    Schizophr Res; 2015 Nov; 168(3):634-9. PubMed ID: 25979306
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Convergence and divergence in the neurochemical regulation of prepulse inhibition of startle and N40 suppression in rats.
    Swerdlow NR; Geyer MA; Shoemaker JM; Light GA; Braff DL; Stevens KE; Sharp R; Breier M; Neary A; Auerbach PP
    Neuropsychopharmacology; 2006 Mar; 31(3):506-15. PubMed ID: 16123772
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hippocampal and cortical sensory gating in rats: effects of quinpirole microinjections in nucleus accumbens core and shell.
    de Bruin NM; Ellenbroek BA; van Luijtelaar EL; Cools AR; Stevens KE
    Neuroscience; 2001; 105(1):169-80. PubMed ID: 11483310
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sensorimotor gating in rats is regulated by different dopamine-glutamate interactions in the nucleus accumbens core and shell subregions.
    Wan FJ; Swerdlow NR
    Brain Res; 1996 May; 722(1-2):168-76. PubMed ID: 8813362
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neurotensin-deficient mice have deficits in prepulse inhibition: restoration by clozapine but not haloperidol, olanzapine, or quetiapine.
    Kinkead B; Dobner PR; Egnatashvili V; Murray T; Deitemeyer N; Nemeroff CB
    J Pharmacol Exp Ther; 2005 Oct; 315(1):256-64. PubMed ID: 15987829
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neonatal exposure to epidermal growth factor induces dopamine D2-like receptor supersensitivity in adult sensorimotor gating.
    Sotoyama H; Namba H; Takei N; Nawa H
    Psychopharmacology (Berl); 2007 Apr; 191(3):783-92. PubMed ID: 17096084
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Presynaptic dopamine-glutamate interactions in the nucleus accumbens regulate sensorimotor gating.
    Wan FJ; Geyer MA; Swerdlow NR
    Psychopharmacology (Berl); 1995 Aug; 120(4):433-41. PubMed ID: 8539324
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessing the validity of an animal model of deficient sensorimotor gating in schizophrenic patients.
    Swerdlow NR; Braff DL; Taaid N; Geyer MA
    Arch Gen Psychiatry; 1994 Feb; 51(2):139-54. PubMed ID: 8297213
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antipsychotic effects on prepulse inhibition in normal 'low gating' humans and rats.
    Swerdlow NR; Talledo J; Sutherland AN; Nagy D; Shoemaker JM
    Neuropsychopharmacology; 2006 Sep; 31(9):2011-21. PubMed ID: 16482083
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Repeated quinpirole treatment increases cAMP-dependent protein kinase activity and CREB phosphorylation in nucleus accumbens and reverses quinpirole-induced sensorimotor gating deficits in rats.
    Culm KE; Lugo-Escobar N; Hope BT; Hammer RP
    Neuropsychopharmacology; 2004 Oct; 29(10):1823-30. PubMed ID: 15138441
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dissociable effects of the
    Lins BR; Marks WN; Phillips AG; Howland JG
    Psychopharmacology (Berl); 2017 Apr; 234(7):1079-1091. PubMed ID: 28180960
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Seroquel (ICI 204,636) restores prepulse inhibition of acoustic startle in apomorphine-treated rats: Similarities to clozapine.
    Swerdlow NR; Zisook D; Taaid N
    Psychopharmacology (Berl); 1994 May; 114(4):675-8. PubMed ID: 7855231
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Putative antipsychotics with pronounced agonism at serotonin 5-HT1A and partial agonist activity at dopamine D2 receptors disrupt basal PPI of the startle reflex in rats.
    Auclair AL; Galinier A; Besnard J; Newman-Tancredi A; Depoortère R
    Psychopharmacology (Berl); 2007 Jul; 193(1):45-54. PubMed ID: 17393144
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PHNO, a selective dopamine D2 receptor agonist, does not reduce prepulse inhibition of the startle reflex in rats.
    Martin-Iverson MT; Else D
    Psychopharmacology (Berl); 2000 Jul; 151(1):38-48. PubMed ID: 10958115
    [TBL] [Abstract][Full Text] [Related]  

  • 38. GABAergic projection from nucleus accumbens to ventral pallidum mediates dopamine-induced sensorimotor gating deficits of acoustic startle in rats.
    Swerdlow NR; Braff DL; Geyer MA
    Brain Res; 1990 Nov; 532(1-2):146-50. PubMed ID: 2282510
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modulation of mGlu5 improves sensorimotor gating deficits in rats neonatally treated with quinpirole through changes in dopamine D2 signaling.
    Brown RW; Varnum CG; Wills LJ; Peeters LD; Gass JT
    Pharmacol Biochem Behav; 2021 Dec; 211():173292. PubMed ID: 34710401
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quinelorane, a dopamine D3/D2 receptor agonist, reduces prepulse inhibition of startle and ventral pallidal GABA efflux: time course studies.
    Qu Y; Swerdlow NR; Weber M; Stouffer D; Parsons LH
    Pharmacol Biochem Behav; 2008 Oct; 90(4):686-90. PubMed ID: 18579193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.